3-D MatrixDMTRF 55 Days Payable is 110.71 as of Jan. 2026, which is 34% below its 10-year median of 168.51. GuruFocus rates DMTRF with a GF Score™ of 55/100 and a GF Value™ of $2.15 (Fairly Valued). The stock has 3 warning signs investors should review. Among 795 Medical Devices & Instruments companies, 3-D Matrix ranks better than 69.56% on this metric.
3-D Matrix's average Accounts Payable for the
three
months ended in Jan. 2026 was $4.20 Mil. 3-D Matrix's Cost of Goods Sold for the
three
months ended in Jan. 2026 was $3.46 Mil.
Hence, 3-D Matrix's Days Payable for the
three
months ended in Jan. 2026 was 110.71.
The historical rank and industry rank for 3-D Matrix's Days Payable or its related term are showing as below:
DMTRF'
s Days Payable Range Over the Past 10 Years
Min: 69.62 Med: 168.51 Max: 866.19
Current: 108.63
During the past 13 years, 3-D Matrix's highest Days Payable was 866.19. The lowest was 69.62. And the median was 168.51.
DMTRF's Days Payable is ranked better than 69.56% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 67.87
vs DMTRF: 108.63
3-D Matrix's Days Payable
increased
from Jan. 2025 (96.63) to Jan. 2026 (110.71).
It may suggest that 3-D Matrixdelayed paying its suppliers.
3-D Matrix Days Payable Related Terms
3-D Matrix Days Payable Historical Data
* Premium members only.
The historical data trend for 3-D Matrix's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, 3-D Matrix's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
3-D Matrix Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, 3-D Matrix's Days Payable distribution charts can be found below:
* The bar in red indicates where 3-D Matrix's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
3-D Matrix's Days Payable for the fiscal year that ended in Apr. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
3-D Matrix (DMTRF) has a Days Payable of 110.71 as of Jan. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on 3-D Matrix and its competitors. This is 34% below median its historical median of 168.51. Over the past decade, 3-D Matrix's Days Payable has ranged from 69.62 to 866.19. According to the industry distribution chart, 3-D Matrix ranks #242 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 30.4%.
Is 3-D Matrix's Days Payable too high?
3-D Matrix's current Days Payable of 110.71 is 34% below median its 10-year median of 168.51. Over the past 10 years, this metric has ranged from a low of 69.62 to a high of 866.19. The Medical Devices & Instruments industry median Days Payable is 67.87. 3-D Matrix's value of 110.71 is 63.1% above this industry median. Based on the distribution chart, 3-D Matrix ranks #242 out of 795 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, 3-D Matrix has a GF Score™ of 55/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does 3-D Matrix's Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, 3-D Matrix ranks #242 out of 795 companies for Days Payable. This puts 3-D Matrix in the upper half of its industry. The industry median Days Payable is 67.87. 3-D Matrix's value of 110.71 is 63.1% above this benchmark. Historically, 3-D Matrix's own Days Payable has ranged from 69.62 to 866.19 over the past decade. While the company's 10-year median is 168.51 vs. the industry median of 67.87, 3-D Matrix has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.87, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. 3-D Matrix's current Days Payable of 110.71 is 63.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on 3-D Matrix and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. 3-D Matrix's current Days Payable is 110.71, which is 34% below median its own 10-year median of 168.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 3-D Matrix stock overvalued right now?
Based on GuruFocus' analysis, 3-D Matrix (DMTRF) is currently considered Fairly Valued. The stock's GF Value™ is $2.15, compared to a current price of $2.25 — trading 4.7% above its estimated fair value. The current Days Payable is 110.71, which is 34% below median its 10-year median of 168.51 and 63.1% above the Medical Devices & Instruments industry median of 67.87. 3-D Matrix's overall GF Score™ is 55/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For 3-D Matrix (DMTRF), the current Days Payable is 110.71 as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is 3-D Matrix (DMTRF) Overvalued in 2026?
Based on GuruFocus' analysis, 3-D Matrix stock appears to be overvalued.
The current stock price of $2.25 is trading 4.7% above its estimated GF Value™ of $2.15.
GuruFocus considers 3-D Matrix to be Fairly Valued.
Key valuation signals for DMTRF:
Days Payable: 110.71 (34% below median its 10-year median of 168.51)
GF Value™: $2.15 vs. price of $2.25 (4.7% above fair value)
Industry Position: 63.1% above the Medical Devices & Instruments median (#242 of 795)
No single metric tells the full story. See the DMTRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
3-D Matrix Ltd is engaged in the research, development, manufacture, and sale of medical devices based on the self-assembling peptide technology. Its products include PuraMatrix, High Concentration PuraMatrix, Modified Peptide and GMP Grade PuraMatrix.
55GF Score
Get the complete analysis for DMTRF
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DMTRF has been successfully added to your 
